Tumors

Alrizomadlin may restore efficacy of PD-1 blockade in immunotherapy-resistant tumors

Posted on: Jun 10, 2021   |   Posted by: Health Mag

Alrizomadlin may restore efficacy of PD-1 blockade in immunotherapy-resistant tumors

Use of alrizomadlin with pembrolizumab appeared to restore the antitumor effects of the anti-PD-1 antibody among patients with melanoma resistant to or intolerant of...

Continue reading ...